Haleon reports US sales growth by targeting GLP-1 drug users
Haleon says it is growing US sales of consumer-health products aimed at countering side-effects of weight-loss drugs as GLP-1 use rises.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.